ImportRefusal LogoImportRefusal

Blue Cross Bio-Medical (Beijing) Co., Ltd.

⚠️ Moderate Risk

FEI: 3005554520 • Beijing • CHINA

FEI

FEI Number

3005554520

📍

Location

Beijing

🇨🇳

Country

CHINA
🏢

Address

Beiqija Industry Zone, Changping District, Beijing, , China

Moderate Risk

FDA Import Risk Assessment

32.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

10
Total Refusals
4
Unique Violations
12/3/2020
Latest Refusal
8/2/2002
Earliest Refusal

Score Breakdown

Violation Severity
50.0×40%
Refusal Volume
38.6×30%
Recency
0.0×20%
Frequency
5.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

3415×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

712×

NO LICENSE

The article is subject to refusal of admission under section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act (FD&C Act) because it appears to be a biological product for which a biologics license is not in effect under the Public Health Service Act, Part F, Subpart 1-Biological Products, Section 351(a), and it is not the subject of an Investigational New Drug application that is in effect. Therefore, it appears to be a new drug under 201(p) of the FD&C Act that it is in violation of section 505(a) of the FD&C Act because it lacks a new drug approval and because it is misbranded under section 502(f)(1)of the FD&C Act because it fails to bear adequate directions for use

5081×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

Refusal History

DateProductViolationsDivision
12/3/2020
79GDZHANDLE, SCALPEL
118NOT LISTED
Division of Southeast Imports (DSEI)
10/5/2015
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
341REGISTERED
Division of Northeast Imports (DNEI)
5/5/2015
80LDQDEVICE, GENERAL MEDICAL
341REGISTERED
Division of Northeast Imports (DNEI)
5/5/2015
83JSXKIT, IDENTIFICATION, NEISSERIA GONORRHOEAE
341REGISTERED
Division of Northeast Imports (DNEI)
5/5/2015
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
341REGISTERED
Division of Northeast Imports (DNEI)
12/16/2009
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
118NOT LISTED
New Orleans District Office (NOL-DO)
12/16/2009
75LCXKIT, TEST, PREGNANCY, HCG, OVER THE COUNTER
118NOT LISTED
New Orleans District Office (NOL-DO)
2/15/2005
82MZFTEST, HIV DETECTION
341REGISTERED
508NO 510(K)
Florida District Office (FLA-DO)
5/15/2003
57FY10ANTI-INFLUENZA VIRUS SERUM (HEMAGGLUTINATION INHIBITION TEST) (IN-VITRO DIAGNOSTIC PRODUCTS)
71NO LICENSE
Florida District Office (FLA-DO)
8/2/2002
57FY10ANTI-INFLUENZA VIRUS SERUM (HEMAGGLUTINATION INHIBITION TEST) (IN-VITRO DIAGNOSTIC PRODUCTS)
118NOT LISTED
71NO LICENSE
Florida District Office (FLA-DO)

Frequently Asked Questions

What is Blue Cross Bio-Medical (Beijing) Co., Ltd.'s FDA import refusal history?

Blue Cross Bio-Medical (Beijing) Co., Ltd. (FEI: 3005554520) has 10 FDA import refusal record(s) in our database, spanning from 8/2/2002 to 12/3/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Blue Cross Bio-Medical (Beijing) Co., Ltd.'s FEI number is 3005554520.

What types of violations has Blue Cross Bio-Medical (Beijing) Co., Ltd. received?

Blue Cross Bio-Medical (Beijing) Co., Ltd. has been cited for 4 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Blue Cross Bio-Medical (Beijing) Co., Ltd. come from?

All FDA import refusal data for Blue Cross Bio-Medical (Beijing) Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.